Pretražite po imenu i prezimenu autora, mentora, urednika, prevoditelja

Napredna pretraga

Pregled bibliografske jedinice broj: 1279476

Ex Vivo Pig Eye Model for Studying Diffusion of Acylcarnitines with Different Physicochemical Properties


Hiller, John Kim; Sandås, Elise Mørk; Rootwelt, Helge; Østeby Vassli, Anja; Utheim, Tor Paaske; Moe, Morten Carstens; Elgstøen, Katja Benedikte Prestø; Petrovski, Goran
Ex Vivo Pig Eye Model for Studying Diffusion of Acylcarnitines with Different Physicochemical Properties // Journal of ocular pharmacology and therapeutics (2023) doi:10.1089/jop.2022.0159 (znanstveni, online first)


CROSBI ID: 1279476 Za ispravke kontaktirajte CROSBI podršku putem web obrasca

Naslov
Ex Vivo Pig Eye Model for Studying Diffusion of Acylcarnitines with Different Physicochemical Properties

Autori
Hiller, John Kim ; Sandås, Elise Mørk ; Rootwelt, Helge ; Østeby Vassli, Anja ; Utheim, Tor Paaske ; Moe, Morten Carstens ; Elgstøen, Katja Benedikte Prestø ; Petrovski, Goran

Vrsta, podvrsta
Radovi u časopisima, znanstveni

Izvornik
Journal of ocular pharmacology and therapeutics (2023)

Status rada
Online first

Ključne riječi
single intravitreal injection ; intraocular pharmacokinetics ; diabetic-retinopathy ; uveoscleral outflow ; bevacizumab ; safety ; complications ; management ; efficacy ; drugs

Sažetak
Purpose: To explore the diffusion capacities between the anterior and vitreous chambers in a novel ex vivo pig eye model using a mix of stable isotope-labeled acylcarnitines representing metabolites with different physical and chemical properties, and analysis using mass spectrometry (MS).Methods: Enucleated pig eyes were injected in the anterior or vitreous chamber of the eye with a stable isotope-labeled acylcarnitine mix (free carnitine, C2, C3, C4, C8, C12, and C16-having an increasing size and hydrophobicity in that order). Samples were collected from each chamber at 3, 6, and 24 h postincubation for analysis using MS.Results: After injection into the anterior chamber, the concentration of all acylcarnitines increased in the vitreous chamber over the observation period. After injection in the vitreous chamber, the acylcarnitines diffused to the anterior chamber with the highest concentration observed at 3 h postinjection, followed by a decrease in concentration possibly due to an elimination from the anterior chamber despite continued diffusion from the vitreous chamber. C16, the most hydrophobic and longest chain molecule, showed slower diffusion in both experimental settings.Conclusion: We hereby show a distinct diffusion pattern of molecules with different molecular size and hydrophobicity within and between the anterior and vitreous chamber. This model can be useful for optimizing choices and design of therapeutic molecules with higher retaining or depot properties into the two chambers of the eye for future intravitreal, intracameral, and topical treatment purposes.

Izvorni jezik
Engleski

Znanstvena područja
Kliničke medicinske znanosti



POVEZANOST RADA


Ustanove:
Medicinski fakultet, Split

Poveznice na cjeloviti tekst rada:

doi

Citiraj ovu publikaciju:

Hiller, John Kim; Sandås, Elise Mørk; Rootwelt, Helge; Østeby Vassli, Anja; Utheim, Tor Paaske; Moe, Morten Carstens; Elgstøen, Katja Benedikte Prestø; Petrovski, Goran
Ex Vivo Pig Eye Model for Studying Diffusion of Acylcarnitines with Different Physicochemical Properties // Journal of ocular pharmacology and therapeutics (2023) doi:10.1089/jop.2022.0159 (znanstveni, online first)
Hiller, J., Sandås, E., Rootwelt, H., Østeby Vassli, A., Utheim, T., Moe, M., Elgstøen, K. & Petrovski, G. (2023) Ex Vivo Pig Eye Model for Studying Diffusion of Acylcarnitines with Different Physicochemical Properties. Prihvaćen za objavljivanje u Journal of ocular pharmacology and therapeutics. [Preprint] doi:10.1089/jop.2022.0159.
@unknown{unknown, author = {Hiller, John Kim and Sand\aas, Elise M\ork and Rootwelt, Helge and \Osteby Vassli, Anja and Utheim, Tor Paaske and Moe, Morten Carstens and Elgst\oen, Katja Benedikte Prest\o and Petrovski, Goran}, year = {2023}, DOI = {10.1089/jop.2022.0159}, keywords = {single intravitreal injection, intraocular pharmacokinetics, diabetic-retinopathy, uveoscleral outflow, bevacizumab, safety, complications, management, efficacy, drugs}, journal = {Journal of ocular pharmacology and therapeutics}, doi = {10.1089/jop.2022.0159}, title = {Ex Vivo Pig Eye Model for Studying Diffusion of Acylcarnitines with Different Physicochemical Properties}, keyword = {single intravitreal injection, intraocular pharmacokinetics, diabetic-retinopathy, uveoscleral outflow, bevacizumab, safety, complications, management, efficacy, drugs} }
@unknown{unknown, author = {Hiller, John Kim and Sand\aas, Elise M\ork and Rootwelt, Helge and \Osteby Vassli, Anja and Utheim, Tor Paaske and Moe, Morten Carstens and Elgst\oen, Katja Benedikte Prest\o and Petrovski, Goran}, year = {2023}, DOI = {10.1089/jop.2022.0159}, keywords = {single intravitreal injection, intraocular pharmacokinetics, diabetic-retinopathy, uveoscleral outflow, bevacizumab, safety, complications, management, efficacy, drugs}, journal = {Journal of ocular pharmacology and therapeutics}, doi = {10.1089/jop.2022.0159}, title = {Ex Vivo Pig Eye Model for Studying Diffusion of Acylcarnitines with Different Physicochemical Properties}, keyword = {single intravitreal injection, intraocular pharmacokinetics, diabetic-retinopathy, uveoscleral outflow, bevacizumab, safety, complications, management, efficacy, drugs} }

Časopis indeksira:


  • Current Contents Connect (CCC)
  • Web of Science Core Collection (WoSCC)
    • Science Citation Index Expanded (SCI-EXP)
    • SCI-EXP, SSCI i/ili A&HCI
  • Scopus
  • MEDLINE


Citati:





    Contrast
    Increase Font
    Decrease Font
    Dyslexic Font